Sanolium interim report Q1 Jan-Mar 2024
Today Sanolium releases the interim report for the first quarter this year“We have continued developing the company in line with our strategic direction during the first quarter 2024. Im proud to see such progress among our ongoing projects as well as the trust from new customers as we continue on the journey towards a healthier tomorrow,” says Rami Avidan, CEO of Cambio A number of important steps has been taken during Q1: · Frame agreement with Karolinska Institute · Continued preparations for the go live with Sussa, one of the largest IT healthcare projects in Europe ·